Dennis (@GordonGekko83) on getquin

1Mon·

Who of you is invested in $EUZ (+2.46%) and what do you think of the IPO of Pentixapharm?

Are you selling after the IPO or are you holding on to both companies?

$EUZ (+2.46%) Pentixapharm produces radioisotopes for medical applications, etc.

Pentixapharm, on the other hand, concentrates on the production of radiopharmaceuticals for the diagnosis and treatment of diseases, particularly cancer.

I personally find both companies interesting and will continue to hold both.

4 Comments

Brian@TherealBFS

1Mon

Here I have an interesting video where Andreas explains what Eckert und Ziegler does and why the spin-off from Pentixapharm is being made. I haven't yet thought about whether I will keep them, but in general I find the area of application interesting.

The video: https://www.biotechtv.com/post/eckert-and-ziegler-september-9-2024

I would also like to buy more Eckert and Ziegler, but unfortunately it is still a bit too expensive for me. I only have a mini position that I would like to expand.

•

news03@user03

1Mon

I am invested and currently still undecided, to be honest I would have liked it better if they didn't do an IPO. But will probably hold both or sell pentixapharm if they do, no advice :)

•

ZeissJessy@ZeissJessy

1Mon

This means that each shareholder will receive one Pentixapharm share for each Eckert & Ziegler share.

•

finanzperpetuum@finanzperpetuum

1Mon

@ZeissJessy yes, that's what it looks like.
https://transkript.de/artikel/2024/pentixapharm-das-interview-zum-ipo/

•